Institutional Ownership
Processa Pharmaceuticals Inc
CUSIP 74275C403COM SHSPCSAQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
13.0%
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 23, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Connective Capital Management, LLC | 70.7K | $178.6K |
| 2 | Stonepine Capital Management, LLC | 55.0K | $138.9K |
| 3 | Geode Capital Management, LLC | 24.9K | $62.8K |
| 4 | Ubs Group AG | 2.5K | $6.4K |
| 5 | Tower Research Capital LLC (Trc) | 918 | $2.3K |
| 6 | Citigroup Inc | 14 | $35 |
| 7 | Jones Financial Companies Lllp | 7 | $17 |
| 8 | Wells Fargo & Company/Mn | 6 | $15 |